Physician profile
Ramy Mando
NPI 1346770625
$2,367.10
in general payments reported to CMS, 2019-2025
17 companies · $889 in 2025
The $889 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $208 · 2022: $129 · 2023: $449 · 2024: $693 · 2025: $889.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,029.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $427.10 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Amgen INC. | $383.43 | 2022-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $306.76 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $200.68 | 2023-2025 | Verquvo |
| Pfizer INC. | $199.05 | 2023-2025 | |
| Boston Scientific Corporation | $166.57 | 2023-2025 | Watchman Flx, Cds - Mct/Cem Monitoring |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $145.72 | 2023-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $145.71 | 2024-2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $141.15 | 2023-2025 | Camzyos, Eliquis |
| Scpharmaceuticals INC. | $56.38 | 2024-2025 | |
| Novo Nordisk INC | $43.94 | 2024-2025 | Wegovy |
| Siemens Medical Solutions USA, INC. | $33.09 | 2025 | Acuson Origin Diagnostic Ultrasound System |
| Kiniksa Pharmaceuticals International, Plc | $28.00 | 2024 | Arcalyst |
| Chiesi USA, INC. | $24.87 | 2023 | Kengreal |
| Abiomed | $24.84 | 2024 | Impella |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vital Connect, INC | $23.93 | 2025 | Vitalpatch Rtm |
| Cmp Pharma, INC. | $15.88 | 2023 | Carospir, Atorvaliq, Tadliq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramy Mando listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.